Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependent
- Interventions
- Drug: INGAP-PeptideDrug: placebo
- Registration Number
- NCT00071422
- Lead Sponsor
- Exsulin Corporation
- Brief Summary
Insulin is a chemical that the body needs in order to use or store sugar. It is made by a type of cell called a beta cell which resides in an organ known as the pancreas. Type 2 diabetes is a disease where the beta cells are unable to meet a person's insulin needs. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new beta cells in the pancreas, and to improve the ability to produce insulin in type 2 diabetic patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 126
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 600 mg INGAP Peptide INGAP-Peptide 1.5 mL SC injection, once daily for 90 days placebo placebo 1.5 mL SC injection, once daily for 90 days 300 mg INGAP Peptide INGAP-Peptide 1.5 mL SC injection, once daily for 90 days
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (16)
VA Hospital UCSD
🇺🇸San Diego, California, United States
Diabetes and Endocrine Associates
🇺🇸La Jolla, California, United States
Diablo Clinical Research
🇺🇸Walnut Creek, California, United States
Longmont Medical Research Network
🇺🇸Longmont, Colorado, United States
MedStar Clinical Research Center
🇺🇸Washington, District of Columbia, United States
Future Care Studies
🇺🇸Springfield, Massachusetts, United States
Diabetes-Endocrinology Center of WNY
🇺🇸Buffalo, New York, United States
UNC Diabetes Care Center
🇺🇸Durham, North Carolina, United States
Piedmont Medical Group
🇺🇸Winston-Salem, North Carolina, United States
Clinical Research Institute of Southern Oregon
🇺🇸Medford, Oregon, United States
Mountain View Clinical Research
🇺🇸Greer, South Carolina, United States
Dallas Diabetes and Endocrine Center
🇺🇸Dallas, Texas, United States
University of Texas Health Science Center - Texas Diabetes Institute
🇺🇸San Antonio, Texas, United States
DGD Research Associates
🇺🇸San Antonio, Texas, United States
Charlottesville Medical Research
🇺🇸Charlottesville, Virginia, United States
Mercury Street Medical
🇺🇸Butte, Montana, United States